Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6026
CALL
OptimizeRx
OPRX
$160M
| $1.35M | ﹤0.01% |
+43,200
| New | +$1.06M |
|
|
CNH
6027
CALL
CNH Industrial
CNH
$16.5B
| $1.35M | ﹤0.01% |
120,415
+17,809
| +17% | +$155K |
|
|
JMIN
6028
DELISTED
JPMorgan U.S. Minimum Volatility ETF
JMIN
| $1.35M | ﹤0.01% |
42,461
+6,273
| +17% | +$194K |
|
|
TGI
6029
PUT
DELISTED
Triumph Group
TGI
| $1.34M | ﹤0.01% |
107,100
+78,200
| +271% | +$812K |
|
6030
Columbia Diversified Fixed Income Allocation ETF
DIAL
$389M
| $1.34M | ﹤0.01% |
+60,823
| New | +$1.32M |
|
6031
WisdomTree India Earnings Fund ETF
EPI
$2.02B
| $1.34M | ﹤0.01% |
46,016
+35,617
| +343% | +$928K |
|
6032
W&T Offshore
WTI
$566M
| $1.34M | ﹤0.01% |
+619,278
| New | +$1.19M |
|
|
SASR
6033
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.34M | ﹤0.01% |
+41,750
| New | +$1.19M |
|
|
HUYA
6034
PUT
Huya Inc
HUYA
$524M
| $1.34M | ﹤0.01% |
67,400
-92,300
| -58% | -$1.98M |
|
6035
CALL
Ryanair
RYAAY
$29.8B
| $1.34M | ﹤0.01% |
30,500
-14,000
| -31% | -$549K |
|
6036
Sasol
SSL
$7.51B
| $1.34M | ﹤0.01% |
151,359
+124,974
| +474% | +$936K |
|
6037
CALL
Vanguard Total Bond Market
BND
$161B
| $1.34M | ﹤0.01% |
15,200
-4,400
| -22% | -$387K |
|
6038
CALL
iShares MSCI Australia ETF
EWA
$1.41B
| $1.34M | ﹤0.01% |
55,900
-40,800
| -42% | -$902K |
|
6039
CALL
Franklin Resources
BEN
$17.4B
| $1.34M | ﹤0.01% |
53,500
-57,000
| -52% | -$1.27M |
|
|
CCRN
6040
DELISTED
Cross Country Healthcare
CCRN
| $1.34M | ﹤0.01% |
150,708
+96,772
| +179% | +$787K |
|
6041
PUT
CBRE Group
CBRE
$42.8B
| $1.34M | ﹤0.01% |
21,300
-34,500
| -62% | -$1.95M |
|
6042
PUT
Ormat Technologies
ORA
$7.01B
| $1.34M | ﹤0.01% |
14,800
+400
| +3% | +$30.3K |
|
6043
PUT
Medifast
MED
$128M
| $1.33M | ﹤0.01% |
6,800
-1,100
| -14% | -$194K |
|
6044
MYR Group
MYRG
$5.31B
| $1.33M | ﹤0.01% |
22,220
-21,395
| -49% | -$1.06M |
|
6045
PUT
PBF Energy
PBF
$8.9B
| $1.33M | ﹤0.01% |
188,000
+49,800
| +36% | +$325K |
|
6046
CALL
Sprout Social
SPT
$579M
| $1.33M | ﹤0.01% |
29,400
+8,400
| +40% | +$400K |
|
6047
iShares MSCI Finland ETF
EFNL
$255M
| $1.33M | ﹤0.01% |
30,115
+17,299
| +135% | +$733K |
|
6048
PUT
Bio-Techne
TECH
$11.3B
| $1.33M | ﹤0.01% |
16,800
-16,000
| -49% | -$1.16M |
|
6049
PUT
Healthcare Services Group
HCSG
$1.48B
| $1.33M | ﹤0.01% |
47,400
+24,700
| +109% | +$597K |
|
6050
Modine Manufacturing
MOD
$11.5B
| $1.33M | ﹤0.01% |
106,083
-7,830
| -7% | -$75.9K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.